The promiscuity of most kinase inhibitors can cause drug toxicity and complicate the interpretation of experiments. Rather than assessing kinase-compound binding, Anastassiadis et al. use functional assays to profile the activities of 178 commercially available kinase inhibitors against 300 recombinant human protein kinases.
- Theonie Anastassiadis
- Sean W Deacon
- Jeffrey R Peterson
